Drug Trial Radar · NCT06828055
VK2735 for Weight Management Phase 2 (Venture Oral Dosing)
Last checked: Nov 19, 2026Latest source record: Oct 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
280
Actual
Start
Dec 18, 2024
Primary completion
Jun 24, 2025
Study completion Aug 15, 2025
Sponsor
- Lead sponsor
- Viking Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 14, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 2, 13-week randomized, double-blind, placebo-controlled, parallel arm dose-finding study that will evaluate the safety, tolerability, weight loss efficacy, pharmacodynamic effects, and pharmacokinetics of VK2735 Oral Formulation in adults who are obese (BMI ≥30 kg/m2) or who are overweight (BMI ≥27 kg/m2) with at least one weight-related co-morbid condition. VK2735 or matched placebo will be administered once daily.
Conditions
- Weight Loss
Interventions
PlaceboDrug
Matching Placebo to VK2735
VK2735Drug
Active Treatment
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent (relative) change from baseline in body weight after 13 weeks of treatmentTime frame: 13 Weeks
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Viking Clinical Site #111
Peoria, Arizona
Viking Clinical Site #105
Lake Forest, California
Viking Clinical Site #101
Clearwater, Florida
Viking Clinical Site #108
Largo, Florida
Viking Clinical Site #107
Ocoee, Florida
Viking Clinical Site #102
Port Orange, Florida
Viking Clinical Site #100
Indianapolis, Indiana
Viking Clinical Site #110
Louisville, Kentucky
Viking Clinical Site #114
Marrero, Louisiana
Viking Clinical Site #109
City of Saint Peters, Missouri
Viking Clinical Site #112
Kansas City, Missouri
Viking Clinical Site #113
Butte, Montana
Viking Clinical Site #103
Knoxville, Tennessee
Viking Clinical Site #104
Austin, Texas
Viking Clinical Site #106
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.